Estimates Revisions Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Market Closed -
Saudi Arabian S.E.
07:05:19 08/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 63.25 SAR | -1.40% |
|
+0.16% | -0.46% |
| 07/10 | Avalon Pharma, Aurisco to Cooperate on Oligonucleotide Manufacturing in Saudi Arabia | MT |
| 17/09 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- 4016 Stock
- Consensus Middle East Pharmaceutical Industries Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
